|
Issuer: SHS Gesellschaft für Beteiligungsmanagement mbH
/ Key word(s): Disposal/Private Equity
Tuebingen / 13.03.2025 Selfapy GmbH, a digital health pioneer in the field of mental health, has been acquired by MEDICE Health Family, the European market leader in ADHD therapy. As part of the transaction, the investors SHS Capital, Think.Health Ventures, IBB Ventures, and HTGF sold their shares. Selfapy’s CE-certified medical products provide flexible and easily accessible online therapy programs for people with mental health conditions such as depression, generalized anxiety disorder, bulimia nervosa, binge-eating disorder, and chronic pain. The programs are available as an app for smartphones and tablets and can be prescribed by doctors or psychotherapists, with costs covered by Germany’s statutory health insurance system. Developed by clinical psychologists, the programs provide an efficient, guideline-based, and non-medication therapy with proven effectiveness. The acquisition of Selfapy represents another significant step for MEDICE Health Family on its path from a pure pharmaceutical manufacturer to a provider of clinically validated, multimodal healthcare solutions – integrating pharmaceuticals, digital solutions, and nutrition concepts. Founded in 2016 by Nora Blum, Katrin Bermbach, and Farina Schurzfeld, Selfapy aligns seamlessly with the MEDICE Health Family’s strategy of addressing not only the needs of doctors and therapists but also those of patients through digital interventions. "We strive to deliver even more comprehensive patient care while staying mindful of the current challenges in the healthcare system. That is why, for several years, we have been expanding our strong core business in pharmaceuticals to include developments in digital health solutions," explains Dr. med. Katja Pütter-Ammer, Managing Partner at MEDICE, outlining the strategy of the family-run company. "For us, it's not just about what happens during therapy sessions – it's equally important to support doctors, therapists, and patients between sessions and before therapy even begins," adds Dr. med. Dr. oec. Richard Ammer, who runs the family business alongside his wife, Katja Pütter-Ammer. "Selfapy already accounts for 20% of all permanently listed DiGA in the field of mental health. By joining forces with MEDICE and benefiting from their strong presence among doctors and psychotherapists, we can work even more effectively toward our vision: ensuring that no one with a mental health disorder has to wait for help. Together, we want to take digital healthcare to the next level and reach even more people quickly and effectively," says Selfapy CEO Adham Kassab. Dr. Cornelius Maas, Partner at SHS Capital, who served as long-time Chairman of Selfapy’s Advisory Board, comments on the transaction: "We are pleased to have successfully established Selfapy and its digital health applications as an innovative treatment option in the German healthcare market over the past years. With MEDICE as the strategic buyer, we have found the ideal partner for the next phase of Selfapy’s development and wish both companies continued success in their partnership."
For over 75 years, MEDICE has been committed to improving people's health. As a medium-sized, third-generation family-owned company, MEDICE Health Family pursues the goal of creating a healthier world by comprehensively considering and promoting various dimensions of health—mental, physical, social, and environmental. Quality “Made in Germany”: At its locations in Iserlohn and Ringelheim, MEDICE develops and manufactures high-quality prescription (RX) and self-medication (PCC) pharmaceuticals and medical products, successfully marketing them both nationally and internationally. The patient is always at the heart of MEDICE’s activities. To further improve patient care, MEDICE leverages its pharmacological expertise to develop clinically validated multimodal healthcare solutions, integrating pharmaceuticals, digital solutions, and nutrition concepts. These efforts help reduce gaps in healthcare and support individuals at every stage of illness. The establishment of the key pillars Medigital and Medibiom further strengthens this approach. MEDICE Health Family's entrepreneurial actions are inseparable from its commitment to social responsibility. For decades, MEDICE has supported social health, not only through sports and cultural initiatives—primarily at the regional level—but also through sustainable4U GmbH, a subsidiary focused on enhancing natural spaces and promoting sustainable distribution materials to improve environmental health. The values of MEDICE Health Family—future-oriented, value-driven, and family-focused—guide the company. Based on its long-standing tradition as a family business, MEDICE – The Health Family aims to significantly shape the future of medicine in the coming decade. About SHS Capital: SHS Capital is a private equity provider founded in 1993 that invests in healthcare companies in Europe. The focus of the investments is on expansion financing, shareholder changes and succession situations. "Building European Healthcare Champions" is the investment philosophy according to which SHS finances and develops portfolio companies. The Tübingen-based investor takes both minority and majority stakes. The national and international investors in SHS funds include pension funds, funds of funds, foundations, family offices, strategic investors, entrepreneurs and the SHS management team. The equity or equity-like investment of the AIF is up to € 50 million. Volumes in excess of this can be realised with a network of co-investors. In its investment decisions, SHS attaches great importance to the consideration of ESG aspects and has therefore committed itself to the guidelines of the UN PRI. SHS is currently investing from its sixth fund, which was launched in 2022 and has a volume of ca. € 270 million. Are you interested in receiving regular updates about SHS? Subscribe to our PR contact:
Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
